Sector Alpha Week of 2026-09-11
Not SEBI Registered !! Not Investment advice !!
Sector Alpha — machine-written from the numbers · Data as of 2026-09-11

AXISCADES Technologies Ltd

AXISCADES
Aerospace & Defence - Equipments

AXISCADES Technologies Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

Biggest watch item: the P/E sits at the 98th percentile of its own range — the multiple has already done part of the work.

The price is in a confirmed uptrend (88 weeks in) while the P/E sits at the 98th percentile of its own 11-year range. Underneath, the last four quarters read deteriorating — profit −171.4% year on year, and 92% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.

Stage
Deteriorating
fundamental trajectory, 12 quarters
Price
₹1,832
+16.0% 1Y
P/E
238.0×
98th pctile
of its own 11-year range
Revenue (Jun 26)
₹183 Cr
+94.7% YoY
Profit (Jun 26)
₹−15.0 Cr
−171.4% YoY
Operating margin
4.7%
−2.3 pp YoY
ROCE
4%
FY26
ROIC
7.4%
vs WACC 12.0% → −4.6 pp
Cash conversion
92%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

AXISCADES Technologies Ltd trades at ₹1,832, in a confirmed uptrend and 88 weeks into that stage. That is +15.2% against its own 200-day average. It sits at 67% of a 52-week range of ₹1,124 to ₹2,174. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 1 straight week.

Today the stock is in a confirmed uptrend — week 88 of stage 2, confirmed. At ₹1,832 it trades +15.2% versus its 200-day average and sits at 67% of its 52-week range (₹1,124–₹2,174).

Sep 26: ₹1,832 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
+15.2% versus the 200-day line, week 88 of stage 2
Price50-day avg200-day avg
S2S4S4S2₹2,317₹1,798₹1,279₹760₹242₹1,832₹1,591Sep 23Jun 24Mar 25Jan 26Sep 26
S2S4S4S2₹2,317₹1,798₹1,279₹760₹242₹1,832₹1,591Sep 23Mar 25Sep 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (555 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Mar 16Sep 26

Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +719% while the NIFTY 500 moved +267% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 1 straight week — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

AXISCADES Technologies Ltd trades at 238.0× P/E, about the priciest it has ever traded. Its long-run median P/E is 33.1×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 238.0× is about the priciest it has ever traded, against a long-run median of 33.1× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 238.0× vs a 33.1× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 10.5-year window; loss-period spikes above 99× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
about the priciest it has ever traded
P/EMedianEPS (TTM) (quarterly)
106.7×₹23.080.0×₹17.253.4×₹11.526.7×₹5.70.0×₹0.0×99.30×₹8Mar 16Dec 19Apr 22Jul 24Sep 26
106.7×₹23.080.0×₹17.253.4×₹11.526.7×₹5.70.0×₹0.0×99.30×₹8Mar 16Apr 22Sep 26
PEG 0.60 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Computed here as quarter-end P/E ÷ trailing-twelve-month EPS growth (only quarters with positive growth), because a reported quarterly PEG is not held for this stock. Last 8 quarters.
below 1.0, the growth looks cheap against the multiple
PEGPEG = 1.0
2.7×2.1×1.5×0.9×0.3××0.60×Q2 FY24Q1 FY25Q3 FY25Q1 FY26Q3 FY26
2.7×2.1×1.5×0.9×0.3××0.60×Q2 FY24Q3 FY25Q3 FY26
P/E
238.0×
98th percentile of 11y
PEG
n/m
not derivable — 3-year earnings growth unavailable

Why the multiple sits where it does: over the past year annual EPS moved −4.0% against a +16.0% price move — the price outran earnings, pushing the multiple UP its own range.

The price move, decomposed: over 5y, of the +91.5%/yr price move, ~+14.8%/yr came from earnings growth and ~+76.7 pp from the multiple (expanding); over 10y, of the +23.7%/yr price move, ~−3.1%/yr came from earnings growth and ~+26.8 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: Deteriorating

Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

AXISCADES Technologies Ltd reads as deteriorating on its fundamental arc. Deteriorating — profit and EPS growth are shrinking (profit growth −55.0% latest against +188.0% at its 12-quarter best), ROCE holding at 14.5%. The read is built from 12 quarters across 4 curves, on full evidence.

Growth, year by year: revenue −48.5% in FY26, profit −4.0% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
41%151%17%64%−6.9%−23%−31%−110%−55%−197%%%−48.5%−4%FY16FY21FY26
41%151%17%64%−6.9%−23%−31%−110%−55%−197%%%−48.5%−4%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue accelerating, profit rolling over
RevenueProfitEPS
27%211%15%140%2.5%68%−9.4%−3.2%−21%−75%%%3.5%−55%−53.8%Sep 23Dec 24Jun 26
27%211%15%140%2.5%68%−9.4%−3.2%−21%−75%%%3.5%−55%−53.8%Sep 23Dec 24Jun 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
22%20%18%16%14%%14.5%Sep 23Mar 24Dec 24Sep 25Jun 26
22%20%18%16%14%%14.5%Sep 23Dec 24Jun 26
Revenue growth
Recovering
latest +3.5% · span −18.1% to +23.2%
Profit growth
Falling
latest −55.0% · span −55.0% to +188.0%
EPS growth
Falling
latest −53.8% · span −53.8% to +191.5%
ROCE
Stuck low
latest 14.5% · span 14.2%–21.1%

🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue−48.5%−13.6%+0.3%+3.5%
Profit−4.0%+9.5%
EPS−4.0%+4.9%
Share price+16.0%+46.9%+91.5%+23.7%
Revenue YoY (Jun 26)
+94.7%
latest quarter vs a year ago
Profit YoY (Jun 26)
−171.4%
latest quarter vs a year ago
Revenue 10y
3.5%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

33.1/100 — rank 21 of 25 in Aerospace & Defence - Equipments · 93% evidence confidence

AXISCADES Technologies Ltd scores 33.1 out of 100 against the 25 companies it is compared with in Aerospace & Defence - Equipments, ranking 21. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 11.9 + 3.9 + 10.9 + 6.4 = 33.1. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

AXISCADES Technologies Ltd reported ₹183 Cr of revenue in the Jun 26 quarter, +94.7% year on year. Over 10 years it has compounded at 3.5% a year. The last full year, FY26, came in at ₹531 Cr. The last four reported quarters add to ₹934 Cr.

FY26 revenue came in at ₹531 Cr (−48.5% on the year), capping 10 years at 3.5% compound. The latest quarter (Jun 26) printed ₹183 Cr, +94.7% year on year.

FY26 revenue ₹531 Cr (−48.5% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
3.5% a year over 10 years
RevenueYoY growth
1.1k41%83517%557−6.9%278−31%0−55%₹ Cr%₹531−48.5%FY16FY21FY26
1.1k41%83517%557−6.9%278−31%0−55%₹ Cr%₹531−48.5%FY16FY21FY26
Jun 26: ₹183 Cr (+94.7% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Revenue (quarterly)YoY growth
370107%27862%18518%93−27%0−72%₹ Cr%₹18394.7%Sep 23Dec 24Jun 26
370107%27862%18518%93−27%0−72%₹ Cr%₹18394.7%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged +18.2% growth against the decade's 3.5% — the current year is running faster than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +3.5% over the last 4 quarters against −1.6%/yr over the last 8 — accelerating; TTM profit −55.0% vs −10.6%/yr — rolling over.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

AXISCADES Technologies Ltd's operating margin is 4.7% in the Jun 26 quarter, −2.3 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 2.2% to 18.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 4.7%, −2.3 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 2.2%–18.0%.

🚨 Why the margin moved: operating margin went −2.5 pp year on year while gross margin went −12.7 pp — the loss came mostly from the gross line: input costs and pricing.

FY26: 9.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a 2.2–18.0% band over 13 years
operating marginYoY change (pp)
19%13%15%8.1%10%2.9%5.5%−2.3%0.9%−7.4%%%9%−5%FY14FY20FY26
19%13%15%8.1%10%2.9%5.5%−2.3%0.9%−7.4%%%9%−5%FY14FY20FY26
Jun 26: 4.7% operating margin (−2.3 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
19%4.3%14%−0.5%9.2%−5.3%4.0%−10%−1.1%−15%%%4.7%−2.3%Sep 23Dec 24Jun 26
19%4.3%14%−0.5%9.2%−5.3%4.0%−10%−1.1%−15%%%4.7%−2.3%Sep 23Dec 24Jun 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

AXISCADES Technologies Ltd posted a net loss of ₹15.0 Cr in the Jun 26 quarter. Full-year FY26 profit was ₹72.0 Cr. The 10-year compound rate is 9.5%. That loss is 8.2% of the quarter's revenue. The same quarter a year earlier earned ₹21.0 Cr. 1 of the last 12 reported quarters were loss-making.

Jun 26 profit was ₹−15.0 Cr, −171.4% year on year. On the full year, FY26 printed ₹72.0 Cr (−4.0%), and the 10-year compound rate is 9.5%.

FY26 profit ₹72.0 Cr (−4.0% YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
9.5% a year over 10 years
Net profitYoY growth
83151%5565%27−21%0−108%−29−194%₹ Cr%₹72−4%FY16FY21FY26
83151%5565%27−21%0−108%−29−194%₹ Cr%₹72−4%FY16FY21FY26
Jun 26: ₹−15.0 Cr (−171.4% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
36290%22166%942%−5−82%−19−206%₹ Cr%₹−15−171.4%Sep 23Dec 24Jun 26
36290%22166%942%−5−82%−19−206%₹ Cr%₹−15−171.4%Sep 23Dec 24Jun 26

🚨 Why profit moved: revenue contributed +94.7% and the margin −2.3 pp — the quarter was revenue-led despite a thinner margin.

Pace comparison, last four quarters: profit −23.3% vs revenue +18.2%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 92% of AXISCADES Technologies Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹−1.0 Cr of operating cash against ₹72.0 Cr of profit. After ₹131 Cr of capital spending, ₹−132 Cr was left as free cash.

FY26: operating cash of ₹−1.0 Cr against reported profit of ₹72.0 Cr, leaving free cash of ₹−132 Cr after ₹131 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 92% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹−1.0 Cr vs profit ₹72.0 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 11-year window, annual resolution. FY17/FY18 reflects an acquisition year — point shown clipped.
92% of 3-year profit arrived as cash
Operating cashNet profitFree cash
18810216−70−156₹ Cr₹−1₹72₹−132FY16FY21FY26
18810216−70−156₹ Cr₹−1₹72₹−132FY16FY21FY26
FY26: CFO = −1% of profit (three-year rate 92%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash.
Conversion100%
258%189%119%49%−20%%−1%FY16FY21FY26
258%189%119%49%−20%%−1%FY16FY21FY26

Why conversion sits at 92%: the cash cycle stretched 196 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.

Router verdict: the bigger cash user is investment — capital spending ran 3.0× depreciation over three years, so the next section's job is to check what that build-out is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

AXISCADES Technologies Ltd's cash conversion cycle runs 184 days in FY26, up from −12 days in FY21. Capital spending ran ₹299 Cr over the last 3 years. At FY26 sales of ₹531 Cr each day of that cycle holds about ₹1.5 Cr, so roughly ₹268 Cr sits inside the business at any moment.

FY26: debtors at 283 days, inventory at 121 days — roughly 4.0 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 184 days, looser than FY21's −12.

The full loop: cash goes out to suppliers and production on day 0; stock waits 121 days to sell; customers pay about 283 days after that; and suppliers themselves are paid at 221 days — netting out to the 184-day cycle.

In money terms: at FY26 sales of ₹531 Cr, each day of the cycle holds about ₹1.5 Cr — so the 184-day loop keeps roughly ₹268 Cr sitting inside the business at any moment.

FY26: a 184-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 13-year window.
+196 days vs FY21
Cash cycleInventory daysDebtor daysPayable days
36624712910−109days184d121d283d221dFY14FY17FY20FY23FY26
36624712910−109days184d121d283d221dFY14FY20FY26

On the investment side: capital spending of ₹299 Cr over the last 3 fiscal years against ₹99.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹44.0 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹131 Cr, work-in-progress ₹44.0 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
a build-out
CapexWork-in-progress
217148788−61₹ Cr₹131₹44FY16FY18FY21FY23FY26
217148788−61₹ Cr₹131₹44FY16FY21FY26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

AXISCADES Technologies Ltd earns a ROCE of 4% in FY26. That is up from a trough of 1% in FY19. Return on invested capital clears the cost of that capital by −4.6 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 13.6% net margin on 0.36× asset turns.

FY26 ROCE is 4%, recovered from a FY19 trough of 1% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY26): 13.6% net margin × 0.36× asset turns × 2.02× balance-sheet leverage ≈ 9.9% on equity. Margin does its share; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: 7.4% − 12.0% = a −4.6 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY26: ROCE 4% Return on capital employed by fiscal year, % (line); ROIC by fiscal year, % (line). 13-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the climb back from FY19's 1%
ROCEROIC (annual)WACC
31%21%11%1.0%−8.9%%4%9.1%FY14FY20FY26
31%21%11%1.0%−8.9%%4%9.1%FY14FY20FY26
Q4 FY26: ROCE 14.4% (TTM) vs WACC 12.0% Trailing-twelve-month ROCE and ROIC, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROCE (TTM)ROIC (TTM)WACC
25%20%16%12%7.3%%14.4%13.1%Q1 FY24Q2 FY25Q4 FY26
25%20%16%12%7.3%%14.4%13.1%Q1 FY24Q2 FY25Q4 FY26
11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

AXISCADES Technologies Ltd carries total debt of ₹388 Cr against shareholder equity of ₹734 Cr as of Mar 26, a debt-to-equity of 0.53. On the annual view that ratio went from 0.21 in FY22 to 0.53 in FY26. Read the returns elsewhere on this page with that leverage in mind.

Mar 26: total debt of ₹388 Cr against shareholder equity of ₹734 Cr — a debt-to-equity of 0.53. On the annual view, debt-to-equity went from 0.21 (FY22) to 0.53 (FY26). Read the returns on this page with that leverage in mind.

FY26: debt ₹388 Cr at 0.53× equity Total debt by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
4191.1×3140.8×2100.6×1050.4×00.1×₹ Cr×₹3880.53×FY22FY24FY26
4191.1×3140.8×2100.6×1050.4×00.1×₹ Cr×₹3880.53×FY22FY24FY26
Mar 26: debt ₹388 Cr, debt-to-equity 0.53 Total debt per quarter, ₹ Cr (bars); debt-to-equity, × (line). Last 12 quarters. India reports the full balance sheet half-yearly, so the intervening quarter carries the prior reading forward.
Total debt (quarterly)Debt-to-equity
4691.2×3521.0×2340.8×1170.5×00.3×₹ Cr×₹3880.53×Jun 23Sep 24Mar 26
4691.2×3521.0×2340.8×1170.5×00.3×₹ Cr×₹3880.53×Jun 23Sep 24Mar 26
12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Domestic institutions cut 2.6 points of AXISCADES Technologies Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 2.0% of the company. Promoters moved −2.2 points over the same window, to 58.0%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Domestic institutions: −2.6 points over 8 quarters to 2.0%; Promoters: −2.2 points over 8 quarters to 58.0%; Foreign institutions: +1.1 points over 8 quarters to 1.4%.

🚨 Why the register moved: domestic institutions drove it (−2.6 points), alongside promoters (−2.2 points) — distribution into the market’s bid.

Fiscal-year ends: promoters −2.3 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
65%48%30%13%−4.4%%58.0%1.2%1.6%39.1%Mar 24Mar 25Mar 26
65%48%30%13%−4.4%%58.0%1.2%1.6%39.1%Mar 24Mar 25Mar 26
Domestic institutions cut 2.6 points over 8 quarters Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
71%52%33%14%−5.3%%58.0%1.4%2.0%38.6%Jun 23Dec 24Jun 26
71%52%33%14%−5.3%%58.0%1.4%2.0%38.6%Jun 23Dec 24Jun 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

AXISCADES Technologies Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · Aerospace & Defence - Equipments
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Sigma Advanced System LtdSIGMAADV 77.9/100Favorable setup82% evidence LEADER 28.4/35 Revenue 100% · PAT 20.3% · OPM change 307 pp 95% evidence 17.2/25 ROCE 60.8% · OPM 16% 76% evidence 12.5/20 P/E 95.1× · PEG — 50% evidence 19.8/20 RS sector 113.1% · RS bench 161.3% · 1Y 481.8%12 of 12 weeks ahead 100% evidence
Exact sum: 28.4 + 17.2 + 12.5 + 19.8 = 77.9 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
2Paras Defence and Space Technologies LtdPARAS 70.7/100Favorable setup82% evidence LEADER 25.8/35 Revenue 36.6% · PAT 54.8% · OPM change 2 pp 95% evidence 17.1/25 ROCE 17.2% · OPM 25% 76% evidence 9.0/20 P/E 125× · PEG — 50% evidence 18.8/20 RS sector 29.1% · RS bench 66.5% · 1Y 117.2%12 of 12 weeks ahead 100% evidence
Exact sum: 25.8 + 17.1 + 9 + 18.8 = 70.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
3MTAR Technologies LtdMTARTECH 67.2/100Favorable setup90% evidence TURNING 30.4/35 Revenue 53.5% · PAT 100% · OPM change 6 pp 100% evidence 15.3/25 ROCE 15.1% · OPM 24% 100% evidence 8.0/20 P/E 165× · PEG — 50% evidence 13.5/20 RS sector 29.8% · RS bench 63% · 1Y 419.4%5 of 12 weeks ahead 100% evidence
Exact sum: 30.4 + 15.3 + 8 + 13.5 = 67.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Azad Engineering LtdAZAD 64.0/100Mixed-positive evidence93% evidence LEADER 24.2/35 Revenue 29% · PAT 41.4% · OPM change 1 pp 100% evidence 12.8/25 ROCE 11.9% · OPM 37% 100% evidence 8.2/20 P/E 132× · PEG 2.29 65% evidence 18.8/20 RS sector 15.1% · RS bench 50.7% · 1Y 80.6%10 of 12 weeks ahead 100% evidence
Exact sum: 24.2 + 12.8 + 8.2 + 18.8 = 64 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5Rossell Techsys LtdROSSTECH 62.9/100Mixed-positive evidence83% evidence BREAKING OUT 28.8/35 Revenue 82.9% · PAT 68.8% · OPM change 1.8 pp 100% evidence 8.0/25 ROCE 11.5% · OPM 14.4% 100% evidence 8.9/20 P/E 173× · PEG — 15% evidence 17.2/20 RS sector 13.1% · RS bench 48.2% · 1Y 69.8%8 of 12 weeks ahead 100% evidence
Exact sum: 28.8 + 8 + 8.9 + 17.2 = 62.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Sika Interplant Systems LtdSIKA 62.4/100Mixed-positive evidence94% evidence BREAKING OUT 19.1/35 Revenue 0.5% · PAT 9.8% · OPM change 1.1 pp 100% evidence 21.9/25 ROCE 34.6% · OPM 19.5% 100% evidence 13.0/20 P/E 66.4× · PEG 1.01 100% evidence 8.4/20 RS sector -10.2% · RS bench 7.8% · 1Y -4.3%8 of 9 weeks ahead 70% evidence
Exact sum: 19.1 + 21.9 + 13 + 8.4 = 62.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7Vinyas Innovative Technologies LtdVINYAS 60.0/100Thin evidence · provisional57% evidence BREAKING OUT 21.7/35 Revenue 65% · PAT 100% · OPM change 3 pp 48% evidence 19.0/25 ROCE 21.4% · OPM 13% 95% evidence 10.8/20 P/E 63.1× · PEG — 15% evidence 8.5/20 RS sector -17.6% · RS bench 31.3% · 1Y 24.9%11 of 11 weeks ahead 70% evidence
Exact sum: 21.7 + 19 + 10.8 + 8.5 = 60 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
8Data Patterns (India) LtdDATAPATTNS 58.3/100Mixed-positive evidence100% evidence LEADER 22.8/35 Revenue 33.9% · PAT 24.2% · OPM change -5 pp 100% evidence 19.8/25 ROCE 21.9% · OPM 27% 100% evidence 3.0/20 P/E 100× · PEG 3.94 100% evidence 12.7/20 RS sector 7.7% · RS bench 40.5% · 1Y 95%10 of 12 weeks ahead 100% evidence
Exact sum: 22.8 + 19.8 + 3 + 12.7 = 58.3 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
9Jaykay Enterprises LtdJAYKAY 54.3/100Mixed-positive evidence74% evidence ASLEEP 29.0/35 Revenue 100% · PAT 100% · OPM change 1.8 pp 95% evidence 8.1/25 ROCE 8.2% · OPM 14.2% 95% evidence 11.1/20 P/E 61.2× · PEG — 15% evidence 6.1/20 RS sector -20.9% · RS bench 1.6% · 1Y 13.3%1 of 10 weeks ahead 70% evidence
Exact sum: 29 + 8.1 + 11.1 + 6.1 = 54.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -20.9% and the one-year return is 13.3%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
10Astra Microwave Products LtdASTRAMICRO 53.5/100Mixed-positive evidence100% evidence LEADER 16.0/35 Revenue 3.9% · PAT 17.4% · OPM change -1 pp 100% evidence 17.7/25 ROCE 20.3% · OPM 19% 100% evidence 4.8/20 P/E 84.4× · PEG 3.3 100% evidence 15.0/20 RS sector 7.8% · RS bench 39.8% · 1Y 66.6%12 of 12 weeks ahead 100% evidence
Exact sum: 16 + 17.7 + 4.8 + 15 = 53.5 · Decision use: Price leads the evidence: RS versus the benchmark is 39.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
11Hindustan Aeronautics LtdHAL 52.3/100Mixed-positive evidence100% evidence BREAKING OUT 13.9/35 Revenue 7.4% · PAT 12.2% · OPM change 1 pp 100% evidence 20.4/25 ROCE 32% · OPM 28% 100% evidence 8.2/20 P/E 35.2× · PEG 3.54 100% evidence 9.8/20 RS sector -17.1% · RS bench 11.6% · 1Y 11.4%8 of 12 weeks ahead 100% evidence
Exact sum: 13.9 + 20.4 + 8.2 + 9.8 = 52.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Apollo Micro Systems LtdAPOLLO 51.8/100Mixed-positive evidence100% evidence FADING 19.6/35 Revenue 68.8% · PAT 74.2% · OPM change -10 pp 100% evidence 13.4/25 ROCE 14.5% · OPM 21% 100% evidence 7.2/20 P/E 129× · PEG 1.6 100% evidence 11.6/20 RS sector 6.4% · RS bench 38.8% · 1Y 38.6%8 of 12 weeks ahead 100% evidence
Exact sum: 19.6 + 13.4 + 7.2 + 11.6 = 51.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13Dynamatic Technologies LtdDYNAMATECH 48.5/100Mixed-negative evidence83% evidence TURNING 18.3/35 Revenue 17.3% · PAT 0% · OPM change 3 pp 100% evidence 9.3/25 ROCE 10.2% · OPM 13% 100% evidence 9.2/20 P/E 140× · PEG — 15% evidence 11.7/20 RS sector -6.1% · RS bench 25% · 1Y 82.9%3 of 12 weeks ahead 100% evidence
Exact sum: 18.3 + 9.3 + 9.2 + 11.7 = 48.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Mishra Dhatu Nigam LtdMIDHANI 45.5/100Mixed-negative evidence100% evidence TURNING 16.6/35 Revenue 18.2% · PAT 13.4% · OPM change -5 pp 100% evidence 11.5/25 ROCE 11.3% · OPM 15% 100% evidence 7.5/20 P/E 62.1× · PEG 5.62 100% evidence 9.9/20 RS sector -9.5% · RS bench 20.5% · 1Y 18.7%4 of 12 weeks ahead 100% evidence
Exact sum: 16.6 + 11.5 + 7.5 + 9.9 = 45.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Bharat Electronics LtdBEL 45.0/100Mixed-negative evidence100% evidence TURNING 14.7/35 Revenue 19.8% · PAT 11.8% · OPM change -3 pp 100% evidence 19.3/25 ROCE 36.4% · OPM 25% 100% evidence 7.5/20 P/E 48.1× · PEG 3.54 100% evidence 3.5/20 RS sector -27.8% · RS bench -2.2% · 1Y 9%0 of 12 weeks ahead 100% evidence
Exact sum: 14.7 + 19.3 + 7.5 + 3.5 = 45 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16Ideaforge Technology LtdIDEAFORGE 44.5/100Mixed-negative evidence74% evidence ASLEEP 26.7/35 Revenue 100% · PAT 100% · OPM change 152.7 pp 74% evidence 1.3/25 ROCE -2.8% · OPM 3.4% 100% evidence 8.5/20 P/E 928× · PEG — 15% evidence 8.0/20 RS sector -3.5% · RS bench 24.1% · 1Y 44.1%7 of 12 weeks ahead 100% evidence
Exact sum: 26.7 + 1.3 + 8.5 + 8 = 44.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17High Energy Batteries (India) Ltd504176 43.3/100Mixed-negative evidence67% evidence TURNING 6.7/35 Revenue 1.5% · PAT -3.5% · OPM change -32.1 pp 95% evidence 14.2/25 ROCE 20.4% · OPM -26.5% 76% evidence 12.3/20 P/E 38.9× · PEG — 50% evidence 10.1/20 RS sector — · RS bench 4.7% · 1Y —4 of 4 weeks ahead 25% evidence
Exact sum: 6.7 + 14.2 + 12.3 + 10.1 = 43.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18Zen Technologies LtdZENTEC 41.4/100Mixed-negative evidence69% evidence FADING 5.1/35 Revenue -23.4% · PAT -27.8% · OPM change -14 pp 95% evidence 16.7/25 ROCE 16.2% · OPM 27% 76% evidence 10.2/20 P/E 85.6× · PEG — 15% evidence 9.4/20 RS sector -6.6% · RS bench 13.1% · 1Y 16.5%5 of 10 weeks ahead 70% evidence
Exact sum: 5.1 + 16.7 + 10.2 + 9.4 = 41.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19BEML LtdBEML 40.5/100Mixed-negative evidence91% evidence BREAKING OUT 15.9/35 Revenue 12.8% · PAT -40.1% · OPM change 8.2 pp 74% evidence 3.5/25 ROCE 7.7% · OPM 0.2% 100% evidence 10.7/20 P/E 94.4× · PEG 1.18 100% evidence 10.4/20 RS sector -17% · RS bench 12% · 1Y -0.9%6 of 12 weeks ahead 100% evidence
Exact sum: 15.9 + 3.5 + 10.7 + 10.4 = 40.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20Bharat Dynamics LtdBDL 35.2/100Mixed-negative evidence93% evidence TURNING 12.1/35 Revenue -18.7% · PAT -7.1% · OPM change 33 pp 100% evidence 13.3/25 ROCE 13.8% · OPM 15% 100% evidence 5.9/20 P/E 83.8× · PEG 4.44 65% evidence 3.9/20 RS sector -35.7% · RS bench -12.4% · 1Y -17.6%2 of 12 weeks ahead 100% evidence
Exact sum: 12.1 + 13.3 + 5.9 + 3.9 = 35.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21AXISCADES Technologies Ltdthis pageAXISCADES 33.1/100Adverse evidence93% evidence ASLEEP 11.9/35 Revenue 3.5% · PAT -55% · OPM change -2.3 pp 100% evidence 3.9/25 ROCE 3.6% · OPM 4.7% 100% evidence 10.9/20 P/E 238× · PEG 1.39 65% evidence 6.4/20 RS sector -12% · RS bench 17% · 1Y 27.5%0 of 12 weeks ahead 100% evidence
Exact sum: 11.9 + 3.9 + 10.9 + 6.4 = 33.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22Avantel LtdAVANTEL 32.1/100Adverse evidence83% evidence ASLEEP 9.9/35 Revenue -3.2% · PAT -67.2% · OPM change 4.6 pp 100% evidence 10.2/25 ROCE 9.6% · OPM 24.8% 100% evidence 8.6/20 P/E 242× · PEG — 15% evidence 3.4/20 RS sector -26.5% · RS bench -1.1% · 1Y -11.6%4 of 12 weeks ahead 100% evidence
Exact sum: 9.9 + 10.2 + 8.6 + 3.4 = 32.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23NIBE LtdNIBE 24.1/100Adverse evidence66% evidence FADING 3.0/35 Revenue -5.2% · PAT -80% · OPM change -24 pp 95% evidence 5.4/25 ROCE 4.8% · OPM -15% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 5.7/20 RS sector -29.8% · RS bench 4.7% · 1Y 7.1%7 of 11 weeks ahead 70% evidence
Exact sum: 3 + 5.4 + 10 + 5.7 = 24.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
24DCX Systems LtdDCXINDIA 24.0/100Adverse evidence71% evidence BASING 5.9/35 Revenue -46.5% · PAT -80% · OPM change -10.9 pp 95% evidence 4.2/25 ROCE 0.9% · OPM -10.4% 95% evidence 10.0/20 P/E — · PEG — 0% evidence 3.9/20 RS sector -27.1% · RS bench -12.3% · 1Y -37.9%1 of 10 weeks ahead 70% evidence
Exact sum: 5.9 + 4.2 + 10 + 3.9 = 24 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25Aequs LtdAEQUS 39.1/100Thin evidence · provisional35% evidence BREAKING OUT 14.9/35 Revenue — · PAT — · OPM change -7.3 pp 45% evidence 4.2/25 ROCE 1.7% · OPM 3.7% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y —12 of 12 weeks ahead 0% evidence
Exact sum: 14.9 + 4.2 + 10 + 10 = 39.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is AXISCADES Technologies Ltd's share price today?

AXISCADES Technologies Ltd trades at ₹1,832, +16.0% over the past year. The company is valued at ₹7,791 Cr. The stock sits at 67% of its 52-week range of ₹1,124–₹2,174, +15.2% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 88 weeks in. — as of 11 September 2026.

What were AXISCADES Technologies Ltd's latest quarterly results?

AXISCADES Technologies Ltd reported revenue of ₹183 Cr and a net loss of ₹15.0 Cr for the Jun 26 quarter. Revenue rose 94.7% and profit fell 171.4% year on year. Earnings per share were ₹−3.49. The operating margin was 4.7%, 2.3 pp lower than a year earlier. — as of 11 September 2026.

What is AXISCADES Technologies Ltd's revenue?

AXISCADES Technologies Ltd reported revenue of ₹183 Cr in the Jun 26 quarter, +94.7% year on year. For the full FY26 fiscal year, revenue was ₹531 Cr (−48.5%). Over the last 10 years revenue compounded at 3.5% a year. — as of 11 September 2026.

What is AXISCADES Technologies Ltd's profit?

AXISCADES Technologies Ltd earned ₹−15.0 Cr of net profit in the Jun 26 quarter, −171.4% year on year. Full-year FY26 profit was ₹72.0 Cr. The operating margin ran 4.7% in the latest quarter. — as of 11 September 2026.

What is AXISCADES Technologies Ltd's market cap?

AXISCADES Technologies Ltd's market capitalisation is ₹7,791 Cr at a share price of ₹1,832. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.

What is AXISCADES Technologies Ltd's P/E ratio?

AXISCADES Technologies Ltd trades at a P/E of 238.0×, at the 98th percentile of its own 11-year range, against a long-run median of 33.1×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.

Does AXISCADES Technologies Ltd pay a dividend?

No — AXISCADES Technologies Ltd has recorded a dividend payout of 0% of profit in each of its last 13 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 11 September 2026.

Is AXISCADES Technologies Ltd overvalued?

On its own history, AXISCADES Technologies Ltd looks expensive: its P/E of 238.0× sits at the 98th percentile of its 11-year range (long-run median 33.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.

Is AXISCADES Technologies Ltd growing?

Not right now — AXISCADES Technologies Ltd's latest numbers are shrinking: latest-quarter revenue +94.7% year on year, profit −171.4%, and the margin −2.3 pp at 4.7%. The 10-year compound rates are 3.5% (revenue) and 9.5% (profit). The earnings engine currently reads: deteriorating — as of 11 September 2026.

How is AXISCADES Technologies Ltd performing?

AXISCADES Technologies Ltd is in a confirmed uptrend, 88 weeks in. Its latest quarter's revenue rose 94.7% and profit fell 171.4% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 11 September 2026.

What stage is AXISCADES Technologies Ltd in?

Deteriorating — profit and EPS growth are shrinking (profit growth −55.0% latest against +188.0% at its 12-quarter best), ROCE holding at 14.5%. The read comes from the last 12 quarters of growth (revenue growth +3.5% latest, profit growth −55.0% latest, eps growth −53.8% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.

Is AXISCADES Technologies Ltd in an uptrend?

Yes — the price is in a confirmed uptrend (week 88 of stage 2), trading +15.2% versus its 200-day average and at 67% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.

Is AXISCADES Technologies Ltd beating the market?

On recent form, yes — AXISCADES Technologies Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 1 straight week, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +719% against the NIFTY 500's +267% — ahead of the index over the full window. — as of 11 September 2026.

Will AXISCADES Technologies Ltd's share price go up?

This page publishes no price forecast for AXISCADES Technologies Ltd. What it measures instead: the share price is ₹1,832, the price is in a confirmed uptrend 88 weeks in. Its P/E of 238.0× sits at the 98th percentile of its own 11-year range. — as of 11 September 2026.

Who owns AXISCADES Technologies Ltd?

Promoters hold 58.0% of AXISCADES Technologies Ltd, foreign institutions 1.4%, domestic institutions 2.0% and the public 38.6% (latest quarter). The biggest move on the register over the last two years: Domestic institutions cut 2.6 points over 8 quarters. — as of 11 September 2026.

Does AXISCADES Technologies Ltd have too much debt?

It is moderate — AXISCADES Technologies Ltd's debt-to-equity is 0.53, and operating profit covers the interest bill 2×. FY26 borrowings were ₹388 Cr against equity of ₹727 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.

What is AXISCADES Technologies Ltd's capex?

AXISCADES Technologies Ltd spent ₹299 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹131 Cr, with ₹44.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.

What is AXISCADES Technologies Ltd's cash flow?

AXISCADES Technologies Ltd consumed ₹1.0 Cr of operating cash in FY26 — cash flowed out rather than in (free cash flow: ₹−132 Cr). Operating cash was negative while the company reported a profit of ₹72.0 Cr. Cash-flow resolution for India is annual. — as of 11 September 2026.

Is AXISCADES Technologies Ltd's profit real cash?

Yes — over the last 3 fiscal years, 92% of AXISCADES Technologies Ltd's reported profit arrived as operating cash. Though the latest year ran at -1% — the trend is the thing to watch. In FY26, operating cash was ₹−1.0 Cr against reported profit of ₹72.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.

Where is AXISCADES Technologies Ltd in its business cycle?

AXISCADES Technologies Ltd's FY26 operating margin was 9.0%, against a 13-year band of 2.2%–18.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 4.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.

What could break the AXISCADES Technologies Ltd story?

Biggest watch item: the P/E sits at the 98th percentile of its own range — the multiple has already done part of the work. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.

Is AXISCADES Technologies Ltd a stock worth studying right now?

This is not investment advice. The machine read: AXISCADES Technologies Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.

Sector Alpha — machine-written from the numbers · Data as of 2026-09-11. Every chart on this page is drawn by deterministic code from the raw series — no forecasts, no price opinions, and nothing here is investment advice.

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI